Readily Diagnostics
Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.
~$970KGates Foundation grant
ParticipantActivity from announced rounds
Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.
Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia